In a world first, Australian leaders in corneal bioengineering have collaborated to form BIENCO, a consortium that will develop bioengineered eye tissue to treat corneal blindness.
All cancers begin as a particular cellular mishap involving DNA. Researchers are working on treatments for all of them. But what if there was a way to prevent that original and universal cellular mishap from happening at all?